Derek Buhl

Scientific Director AbbVie

Seminars

Tuesday 15th September 2026
Precision Psychiatry 2.0: Reimagining Frameworks, Tools & Clinical Pathways to Deliver Individualized Mental Health Care
9:00 am
  •  Positioning EEG as a scalable, translational biomarker, integrating neural signals with clinical and biological data to improve patient stratification and development decision making
  • Moving beyond symptom based diagnoses by leveraging EEG derived neurophysiological signatures to reduce heterogeneity and define biologically coh erent subgroups
  • Translating EEG, digital phenotyping, and AI enabled analytics from research tools into deployable assets across clinical trials, endpoints, and real world settings
  • Aligning pharmacological and non pharmacological interventions with EEG informed neural biomarkers to  guide target engagement, dose selection, and personalized treatment strategies
Tuesday 15th September 2026
Panel Discussion: Evaluating Unmet Needs in Sleep: Navigating EEG Utility & Limitations Across Complex Sleep Architecture
3:15 pm
  •  Defining which facets of sleep (onset, maintenance, early awakening, quality, or EEG specific signals) truly matter as clinical biomarkers
  • Understanding the practical and scientific limits of EEG in psychiatric sleep research: specificity, invasiveness, and placebo susceptibility
  • How sponsors (orexin programs, sleep promoting or circadian targeting drugs) and EEG tech vendors interpret sleep architecture in different disease contexts
  • Identifying core unmet needs in insomnia and sleep dysregulation across mood and psychiatric disorders, and what measurement innovation is required
Tuesday 15th September 2026
Chair’s Opening Remarks
8:55 am
Tuesday 15th September 2026
Chair’s Closing Remarks & End of Focus Day
4:00 pm
Derek Buhl